Chronic Constipation and Mood Disorders Gut Brain Link Study

Introduction

A 2026 study from Nanjing University of Chinese Medicine provides fresh evidence on a concrete biological link between chronic constipation and mood disorders. Researchers identified a specific mitochondrial pathway connecting gut and brain health and demonstrated how a traditional herbal formula, Shugan Tongbian Decoction, can influence it.

Mitochondrial Stress Emerges as a Shared Culprit in Gut and Brain

Scientists led by Haihua Qian and Danae Zhang created a rat model combining constipation-inducing medication with chronic unpredictable mild stress, effectively mimicking patients with functional constipation (FC) and co-occurring anxiety and depression. They focused on a cellular process called the mitochondrial unfolded protein response (UPR^mt). When mitochondria—the powerhouses of cells—become damaged or overwhelmed, they activate UPR^mt as a distress signal. Persistently high UPR^mt is linked to cell dysfunction and death.

The team found that in their dual-symptom model, UPR^mt was significantly elevated in both colon and brain tissues. Electron microscope images revealed visibly damaged mitochondrial structures in these rats. This suggests that the physical discomfort of constipation and the psychological experience of stress may converge on a common point of cellular failure: mitochondrial health. These findings align with other research showing how gut microbiome disruptions can impact immune function and brain health through inflammatory pathways.

A Herbal Formula Targets a Key Cellular Recycling Pathway

The researchers tested Shugan Tongbian Decoction (SGTBD), a traditional formula designed to soothe the liver and promote bowel movement. Rats treated with SGTBD showed measurable improvements in both constipation metrics and behaviors related to anxiety and depression. Crucially, their mitochondrial structures looked healthier.

The team discovered that SGTBD’s benefit appeared to work by modulating the Wnt/Retromer signaling axis. This pathway is essential for cellular housekeeping, including the proper recycling of proteins and the maintenance of mitochondrial integrity. In the diseased rats, this pathway was disrupted. SGTBD treatment restored its function, which subsequently lowered the damaging UPR^mt signal, improved neurotransmitter (serotonin) levels, and protected tissues. This mechanism is distinct from simply increasing fiber or water intake and points to a more foundational repair process. It shares a conceptual similarity with findings that certain antidepressants can improve gut and mood via microbial changes.

What This Means for Understanding IBS and Mental Health

This study shifts the gut-brain conversation slightly but significantly. While much attention has been on neurotransmitters like serotonin and the vagus nerve, this work highlights organelle health as a critical piece. Dysfunctional mitochondria in gut cells could impair motility, while in brain cells they could impair neural communication, creating a two-way street of symptoms.

For individuals with IBS-C (constipation-predominant Irritable Bowel Syndrome) and comorbid depression, the findings offer a biological explanation for why these conditions are so frequently paired. It’s not merely that constipation causes psychological distress; there may be a shared underlying cellular dysfunction exacerbated by stress. This reinforces the observation that constipation significantly increases depression risk.

Furthermore, the study validates the approach of treating the gut-brain axis as a unified system. The successful effect of SGTBD on both organ systems via a single pathway supports integrated treatment models. The research has limitations, of course, being an animal study using a specific herbal blend not widely available clinically, but its mechanistic insight is broadly applicable.

Potential Pathways for Future Treatment and Management

The immediate application of this research is not that everyone should seek out SGTBD, but rather that the mitochondrial and Wnt/Retromer pathways present new targets for therapy. This could influence the development of nutraceuticals or pharmaceuticals designed to support mitochondrial biogenesis and reduce cellular stress in the gut-brain axis.

In practice, this adds weight to lifestyle interventions known to support mitochondrial health, such as regular moderate exercise, a diet rich in polyphenols and antioxidants, and stress-reduction techniques. It also suggests that for refractory cases of IBS-C with mood components, a treatment plan considering cellular energy metabolism might be beneficial. This aligns with emerging data showing how probiotics can augment depression treatment, potentially through modulating systemic inflammation and oxidative stress that affect mitochondria.

Patients and clinicians can view this as a step toward more personalized, mechanism-based approaches to complex gut-brain disorders, moving past symptom management to address potential root causes in cellular communication.

Conclusion

The Nanjing University study provides a detailed map of how mitochondrial dysfunction bridges gut and brain disorders. By identifying the Wnt/Retromer axis as a key regulatory point, it opens new avenues for research and eventually treatment, reinforcing the necessity of a holistic approach to conditions like IBS and depression.

Frequently Asked Questions

Does this mean my depression is caused by bad mitochondria?

Not directly, but this study suggests that for a subset of people with co-occurring constipation and depression, shared mitochondrial stress in gut and brain cells could be a significant contributing factor to both sets of symptoms.

Should I take Shugan Tongbian Decoction for my IBS-C?

This specific herbal formula was used in a controlled animal study and is not a widely standardized or clinically available treatment; you should consult a qualified healthcare practitioner before considering any new herbal regimen.

Can improving my mitochondrial health help my gut and mood?

While more human research is needed, evidence supports that lifestyle choices beneficial for mitochondrial function—like exercise, a nutrient-dense diet, and quality sleep—are independently known to improve both digestive and mental health outcomes.

How does stress fit into this mitochondrial model?

Chronic stress is a known disruptor of mitochondrial function, which could explain why stress often worsens both gastrointestinal symptoms and mood, by pushing already vulnerable cellular systems past a breaking point.

Sources:
https://pubmed.ncbi.nlm.nih.gov/42521002/